Senior executives increase their holdings in Scandion Oncology A/S
Scandion Oncology A/S ("Scandion Oncology") today announces that the Chairman of the Board Jørgen Bardenfleth and Board member Carl Borrebaeck acquire shares from CEO Nils Brünner and CSO Jan Stenvang. Moreover, Nils Brünner and Jan Stenvang acquire shares from former CEO Kim Arvid Nielsen. Below is a description of the transactions. All transactions are done outside the market.Chairman of the Board Jørgen Bardenfleth and Board member Carl Borrebaeck have acquired additional shares in Scandion Oncology. Jørgen Bardenfleth has acquired 23,643 shares in Scandion Oncology from Nils Brünner and